Trials / Completed
CompletedNCT03376516
Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- Male
- Age
- 1 Year – 11 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, non-controlled, international, multi-centre phase 3 study to investigate the pharmacokinetics, efficacy, safety, and immunogenicity of Wilate in previously treated children with severe haemophilia A
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Wilate | von Willebrand factor / Factor VIII (plasma derived) |
Timeline
- Start date
- 2017-11-22
- Primary completion
- 2018-11-03
- Completion
- 2018-11-03
- First posted
- 2017-12-18
- Last updated
- 2021-01-19
- Results posted
- 2019-12-24
Locations
3 sites across 2 countries: Russia, Ukraine
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03376516. Inclusion in this directory is not an endorsement.